Key Details
The World Drug Report 2026 finds that organised drug markets are becoming more synthetic, technologically adaptive and geographically diversified, requiring governments to combine enforcement, public health and international cooperation rather than relying on supply-control measures alone.
Theme | Key Finding |
|---|---|
Global drug use | 331 million people used drugs in 2024, 34% higher than a decade earlier |
Synthetic drugs | Record 755 new psychoactive substances (NPS) identified in 2024 |
Treatment gap | Only one in twelve people with drug use disorders received treatment globally |
Synthetic opioids | Nitazenes are spreading across multiple regions and linked to overdose deaths |
Trafficking | Criminal networks increasingly use smaller consignments, new maritime routes and emerging technologies |
Regional relevance | Asia accounts for 105 million people who use drugs, while opium cultivation patterns are shifting across the region |
Synthetic Drugs Are Changing the Nature of Drug Markets
The report argues that the global drug problem is no longer driven primarily by traditional plant-based narcotics. Synthetic drugs, new psychoactive substances and highly potent synthetic opioids are becoming increasingly prominent because they can be manufactured closer to consumer markets, adapted rapidly and trafficked through more flexible supply chains. This is making drug markets more resilient to conventional enforcement measures.
Trafficking Networks Are Becoming More Adaptive
UNODC finds that organised criminal groups are continually modifying their operations by using smaller consignments, alternative transport routes and technologies such as drones and encrypted communication platforms to reduce detection. At the same time, cocaine production has reached record levels, indicating that expanding enforcement alone has not curtailed global supply.
Public Health Systems Continue to Lag Behind
Despite rising drug consumption, access to treatment remains severely limited. Only one in twelve people with drug use disorders receives treatment, while women continue to face greater barriers to care. The report also highlights the continuing burden of HIV and hepatitis C among people who inject drugs, underscoring the need to strengthen prevention, treatment and harm-reduction services alongside policing.
India’s Regional Environment Is Becoming More Complex
For India, the report signals growing challenges arising from synthetic drugs, shifting opium cultivation patterns and evolving trafficking routes across South and Southeast Asia. The report notes that opium poppy eradication more than doubled in India and Pakistan between 2022 and 2023, reflecting changing cultivation patterns following developments in Afghanistan’s opium economy and wider regional supply adjustments.
Given India’s location between the Golden Crescent and Golden Triangle, these shifts reinforce the need to strengthen precursor-chemical monitoring, forensic capacity, cross-border intelligence sharing and evidence-based prevention and treatment systems to respond to an increasingly dynamic regional drug market.
What are New Psychoactive Substances (NPS)?
New Psychoactive Substances (NPS) are synthetic or naturally occurring substances designed to mimic the effects of internationally controlled drugs while often remaining outside existing legal controls. Their rapidly changing chemical composition makes them difficult to regulate, detect and monitor, creating significant public-health and law-enforcement challenges.
Policy Relevance
Strengthens India’s early-warning systems for detecting synthetic drugs and new psychoactive substances through improved forensic laboratories, intelligence networks and real-time surveillance.
Reinforces the need for the Narcotics Control Bureau to strengthen monitoring of precursor chemicals and adapt enforcement strategies to technology-enabled trafficking methods.
Supports expansion of evidence-based de-addiction, rehabilitation and harm-reduction services under the National Action Plan for Drug Demand Reduction as treatment gaps remain significant.
Highlights the importance of deeper cross-border cooperation with neighbouring countries to respond to changing trafficking routes across the Golden Crescent and Golden Triangle.
Encourages closer integration of public health, organised-crime investigations and financial intelligence to address increasingly sophisticated drug networks.
Suggests that drug policy should increasingly focus on synthetic substances and rapidly emerging psychoactive compounds, rather than relying primarily on crop-eradication strategies.
Follow the Full Report Here: World Drug Report 2026